Research Article
Dihydrolycorine Attenuates Cardiac Fibrosis and Dysfunction by Downregulating Runx1 following Myocardial Infarction
Figure 7
Schematic illustration indicating the cardioprotective effects of dihydrolycorine on myocardial infarction (MI) induced adverse cardiac remodeling.